Instructions of L-Ornithine-L-Aspartate Injection to be revised

On 29 Oct., China's National Medical Products Administration announced to revise instructions of L-Ornithine-L-Aspartate Injection, including its "Adverse Reactions", "Precautions", "Contraindications", "Use in Pregnancy and Nursing Mother", "Pediatr...

Amino Acids China E-News 202011

www.cnchemicals.com